IMGN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: 5.07%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $17,481,291.79

ImmunoGen Insider Trading History Chart

ImmunoGen Share Price & Price History

^$31.23

+0.30 (1.20%)

As of 02/26/2024 01:00 AM ET

Countdown to the biggest trade of my 25 yr career

From Timothy Sykes | Ad

Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… Breaking down the ONE MOVE you must make before the November 5th election to set yourself up for a prosperous 2025.

Click here to see the surprising reason why

ImmunoGen Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/16/2024	Theresa Wingrove	SVP	Sell	187,667	$29.64	$5,562,449.88	3,426
12/26/2023	Renee Lentini	VP	Sell	6,548	$29.74	$194,737.52	8,452
12/15/2023	Theresa Wingrove	SVP	Sell	117,445	$29.40	$3,452,883.00	2,811
11/30/2023	Kristine Peterson	Director	Sell	20,000	$28.90	$578,000.00
11/29/2023	Theresa Wingrove	SVP	Sell	6,792	$16.66	$113,154.72	2,811
11/17/2023	Stacy Ann Coen	SVP	Sell	78,223	$16.05	$1,255,479.15	36,966
11/15/2023	Theresa Wingrove	SVP	Sell	166,725	$15.85	$2,642,591.25	2,811
11/7/2023	Theresa Wingrove	SVP	Sell	19,517	$16.66	$325,153.22	2,811
11/6/2023	Renee Lentini	VP	Sell	219,545	$15.29	$3,356,843.05
10/16/2023	Theresa Wingrove	SVP	Sell	192,004	$14.40	$2,764,857.60	2,811
9/15/2023	Theresa Wingrove	SVP	Sell	192,013	$15.44	$2,964,680.72	2,811
8/9/2023	Stacy Ann Coen	SVP	Sell	100,210	$14.20	$1,422,982.00	10,960
8/4/2023	Stacy Ann Coen	SVP	Sell	80,326	$17.05	$1,369,558.30	10,960
8/3/2023	Mark J. Enyedy	CEO	Sell	1,020,000	$16.61	$16,942,200.00	441,449
8/2/2023	Renee Lentini	Insider	Sell	148,277	$17.55	$2,602,261.35	22,843
8/2/2023	Stacy Ann Coen	SVP	Sell	4,255	$18.12	$77,100.60	10,960

Banking failure dead ahead

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.

SEC Filings (Institutional Ownership Changes) for ImmunoGen (NASDAQ:IMGN)

90.50% of ImmunoGen stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

ImmunoGen Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/29/2024	Kapitalo Investimentos Ltda	31,437	$0.93M	0.2%	N/A	0.012%
3/14/2024	Leo Wealth LLC	25,016	$0.74M	0.1%	N/A	0.009%
3/11/2024	Vanguard Group Inc.	25,466,950	$755.10M	0.0%	+4.0%	9.565%
3/5/2024	Wellington Management Group LLP	1,954,413	$57.95M	0.0%	-85.3%	0.734%
3/5/2024	Twin Focus Capital Partners LLC	31,875	$0.95M	0.1%	-50.1%	0.012%
3/1/2024	Goldman Sachs Group Inc.	1,189,485	$35.27M	0.0%	-4.0%	0.447%
2/28/2024	American International Group Inc.	119,145	$3.53M	0.0%	-0.4%	0.045%
2/23/2024	Chicago Partners Investment Group LLC	11,873	$0.35M	0.0%	N/A	0.004%
2/20/2024	Eventide Asset Management LLC	763,000	$22.62M	0.4%	-41.3%	0.287%
2/20/2024	Readystate Asset Management LP	149,510	$4.43M	0.1%	N/A	0.056%
2/17/2024	FIL Ltd	5,360,000	$158.92M	0.2%	N/A	2.013%
2/15/2024	Westchester Capital Management LLC	1,364,927	$40.47M	1.4%	N/A	0.513%
2/15/2024	Parkwood LLC	25,826	$0.77M	0.1%	N/A	0.010%
2/15/2024	HGC Investment Management Inc.	188,929	$5.60M	1.6%	N/A	0.071%
2/15/2024	Birchview Capital LP	188,000	$5.57M	4.4%	-1.1%	0.071%
2/15/2024	Bridgefront Capital LLC	11,509	$0.34M	0.3%	N/A	0.004%
2/14/2024	TIG Advisors LLC	2,313,670	$68.60M	8.6%	N/A	0.869%
2/14/2024	Twin Securities Inc.	221,622	$6.57M	6.9%	N/A	0.083%
2/14/2024	Avidity Partners Management LP	1,829,215	$54.24M	2.0%	-4.6%	0.687%
2/14/2024	PenderFund Capital Management Ltd.	27,580	$0.82M	0.0%	N/A	0.010%
2/14/2024	P Schoenfeld Asset Management LP	165,000	$4.89M	1.1%	N/A	0.062%
2/14/2024	Superstring Capital Management LP	598,072	$17.73M	12.7%	N/A	0.225%
2/14/2024	Avoro Capital Advisors LLC	875,000	$25.94M	0.4%	N/A	0.329%
2/14/2024	Angelo Gordon & CO. L.P.	80,000	$2.37M	0.8%	N/A	0.030%
2/14/2024	Kynam Capital Management LP	1,422,503	$42.18M	4.7%	N/A	0.534%
2/14/2024	Vazirani Asset Management LLC	200,000	$25K	0.1%	N/A	0.075%
2/14/2024	Harvest Management LLC	214,000	$6.35M	5.9%	N/A	0.080%
2/14/2024	Capital Fund Management S.A.	297,985	$8.84M	0.0%	+364.6%	0.112%
2/14/2024	Water Island Capital LLC	893,758	$26.50M	2.7%	N/A	0.336%
2/14/2024	Sectoral Asset Management Inc.	17,896	$0.53M	0.2%	-96.1%	0.007%
2/14/2024	Bardin Hill Management Partners LP	40,806	$1.21M	0.5%	N/A	0.015%
2/13/2024	GABELLI & Co INVESTMENT ADVISERS INC.	624,750	$18.52M	3.5%	N/A	0.235%
2/13/2024	Gabelli Funds LLC	745,500	$22.10M	0.2%	N/A	0.280%
2/13/2024	DCF Advisers LLC	14,000	$0.42M	0.2%	+8.9%	0.005%
2/13/2024	Armistice Capital LLC	134,698	$3.99M	0.1%	N/A	0.051%
2/13/2024	Affinity Asset Advisors LLC	1,404,608	$41.65M	7.7%	N/A	0.528%
2/13/2024	KRYGER CAPITAL Ltd	2,036,155	$60.37M	9.6%	N/A	0.765%
2/13/2024	Carmignac Gestion	114,380	$3.39M	0.1%	N/A	0.043%
2/13/2024	Rafferty Asset Management LLC	307,369	$9.11M	0.0%	-45.8%	0.115%
2/13/2024	NEOS Investment Management LLC	17,626	$0.52M	0.0%	N/A	0.007%
2/13/2024	KBC Group NV	4,734	$0.14M	0.0%	N/A	0.002%
2/13/2024	California State Teachers Retirement System	250,499	$7.43M	0.0%	+1.7%	0.094%
2/12/2024	Scotia Capital Inc.	19,110	$0.57M	0.0%	+27.6%	0.007%
2/12/2024	Highbridge Capital Management LLC	200,000	$5.93M	0.2%	N/A	0.075%
2/12/2024	Olympiad Research LP	67,137	$1.99M	1.6%	N/A	0.025%
2/12/2024	Decheng Capital LLC	659,928	$19.57M	5.5%	N/A	0.248%
2/12/2024	Allianz Asset Management GmbH	214,350	$6.36M	0.0%	+380.6%	0.081%
2/12/2024	Parallel Advisors LLC	876	$26K	0.0%	+3,028.6%	0.000%
2/12/2024	Artisan Partners Limited Partnership	1,172,323	$34.76M	0.1%	-68.5%	0.440%
2/12/2024	Hsbc Holdings PLC	519,779	$15.44M	0.0%	N/A	0.195%
2/9/2024	Assetmark Inc.	3,880	$0.12M	0.0%	+45.3%	0.001%
2/9/2024	BI Asset Management Fondsmaeglerselskab A S	35,409	$1.05M	0.0%	-55.0%	0.013%
2/9/2024	Dynamic Technology Lab Private Ltd	72,466	$2.15M	0.2%	N/A	0.027%
2/9/2024	Norges Bank	5,539,334	$164.24M	0.0%	N/A	2.080%
2/8/2024	Longfellow Investment Management Co. LLC	2,268	$67K	0.0%	N/A	0.001%
2/8/2024	Panagora Asset Management Inc.	409,658	$12.15M	0.1%	-62.7%	0.154%
2/8/2024	Vanguard Personalized Indexing Management LLC	7,829	$0.23M	0.0%	N/A	0.003%
2/8/2024	Nicholas Investment Partners LP	148,672	$4.41M	0.5%	-92.8%	0.056%
2/7/2024	Principal Financial Group Inc.	1,127,402	$33.43M	0.0%	+14.5%	0.423%
2/7/2024	USA Financial Formulas	3,893	$0.12M	0.0%	N/A	0.001%
2/7/2024	BNP Paribas Financial Markets	137,098	$4.07M	0.0%	-41.9%	0.051%
2/7/2024	Teacher Retirement System of Texas	54,685	$1.62M	0.0%	-12.0%	0.021%
2/7/2024	Versor Investments LP	192,295	$5.70M	1.2%	N/A	0.072%
2/7/2024	Alpine Associates Management Inc.	1,761,300	$52.22M	2.7%	N/A	0.661%
2/7/2024	Kellner Capital LLC	69,200	$2.05M	3.7%	N/A	0.026%
2/7/2024	E Fund Management Co. Ltd.	16,443	$0.49M	0.0%	-43.5%	0.006%
2/7/2024	Segantii Capital Management Ltd	415,000	$12.31M	0.6%	N/A	0.156%
2/6/2024	Charles Schwab Investment Management Inc.	1,892,446	$56.11M	0.0%	+3.4%	0.711%
2/6/2024	BCK Capital Management LP	35,000	$1.04M	1.0%	N/A	0.013%
2/6/2024	MeadowBrook Investment Advisors LLC	1,800	$53K	0.1%	N/A	0.001%
2/6/2024	Amalgamated Bank	29,087	$0.86M	0.0%	-6.4%	0.011%
2/6/2024	Los Angeles Capital Management LLC	42,170	$1.25M	0.0%	-10.2%	0.016%
2/6/2024	Natixis Advisors L.P.	43,254	$1.28M	0.0%	+3.3%	0.016%
2/6/2024	New York Life Investment Management LLC	682,396	$20.23M	0.2%	N/A	0.256%
2/5/2024	Victory Capital Management Inc.	35,213	$1.04M	0.0%	-75.0%	0.013%
2/5/2024	Fernwood Investment Management LLC	83,780	$2.48M	0.6%	-2.9%	0.031%
2/5/2024	Russell Investments Group Ltd.	15,134	$0.45M	0.0%	-14.0%	0.006%
2/1/2024	Wolverine Asset Management LLC	93,223	$2.76M	0.0%	N/A	0.035%
2/1/2024	New York State Common Retirement Fund	146,489	$4.34M	0.0%	-54.9%	0.055%
2/1/2024	Handelsbanken Fonder AB	48,700	$1.44M	0.0%	+10.4%	0.018%
1/31/2024	Calamos Advisors LLC	191,117	$5.67M	0.0%	N/A	0.072%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	50,066	$1.48M	0.0%	+12.0%	0.019%
1/30/2024	Mackenzie Financial Corp	14,265	$0.42M	0.0%	-20.1%	0.005%
1/30/2024	Strs Ohio	47,000	$1.39M	0.0%	+62.1%	0.018%
1/29/2024	Baystate Wealth Management LLC	24,106	$0.72M	0.1%	N/A	0.009%
1/29/2024	Friedenthal Financial	23,440	$0.70M	0.5%	N/A	0.009%
1/25/2024	TFC Financial Management Inc.	10,800	$0.32M	0.1%	-39.8%	0.004%
1/25/2024	Nisa Investment Advisors LLC	6,970	$0.21M	0.0%	+8.4%	0.003%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	127,205	$3.77M	0.0%	-5.2%	0.048%
1/24/2024	DekaBank Deutsche Girozentrale	72,697	$2.15M	0.0%	+4.0%	0.027%
1/24/2024	Arizona State Retirement System	66,111	$1.96M	0.0%	+6.2%	0.025%
1/24/2024	China Universal Asset Management Co. Ltd.	30,961	$0.92M	0.2%	+384.9%	0.012%
1/22/2024	Perkins Capital Management Inc.	10,400	$0.31M	0.3%	-14.0%	0.004%
1/19/2024	Kercheville Advisors LLC	114,897	$3.41M	1.9%	-1.4%	0.043%
1/19/2024	Pinnacle Associates Ltd.	1,011,792	$30M	0.5%	-0.4%	0.380%
1/18/2024	McGlone Suttner Wealth Management Inc.	1,558	$46K	0.0%	N/A	0.001%
1/16/2024	Raymond James Financial Services Advisors Inc.	28,191	$0.84M	0.0%	-9.3%	0.011%
1/16/2024	Raymond James & Associates	104,485	$3.10M	0.0%	-37.6%	0.039%
1/12/2024	SG Americas Securities LLC	128,745	$3.82M	0.0%	+45.9%	0.048%
1/12/2024	First Bank & Trust	19,374	$0.57M	0.1%	N/A	0.007%

Data available starting January 2016

ImmunoGen, Inc., a commercial-stage biotechnology company, focuses on developing and commercializing the antibody-drug conjugates (ADCs) for cancer patients. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), for the treatment of platinum-resistant ovarian cancer; and a cell-surface protein expressed in various epithelial tumors, including ovarian, endometrial, and non-small-cell lung cancers, as well as Pivekimab sunirine, a CD123-targeting ADC that is in Phase II clinical trial for treating acute myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm. Its preclinical programs include IMGC936, an ADC in co-development with MacroGenics, Inc.; and IMGN151, an anti-FRa product candidate. The company has collaborations with Roche; Amgen/Oxford BioTherapeutics; Bayer HealthCare AG; Eli Lilly and Company; Novartis Institutes for BioMedical Research, Inc.; CytomX Therapeutics, Inc.; Fusion Pharmaceuticals Inc.; Debiopharm International SA; and MacroGenics, Inc. ImmunoGen, Inc. was founded in 1980 and is headquartered in Waltham, Massachusetts. As of February 12, 2024, ImmunoGen, Inc. operates as a subsidiary of AbbVie Inc.

Today's Range

Now: $31.23

$31.23

50 Day Range

MA: $31.23

$31.23

52 Week Range

Now: $31.23

$3.61

$31.25

Volume

40 shs

Average Volume

8,778,325 shs

Market Capitalization

$8.32 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.18

Who are the company insiders with the largest holdings of ImmunoGen?: ImmunoGen's top insider shareholders include:
Mark J Enyedy (CEO)
Stacy Ann Coen (SVP)
Renee Lentini (Insider)
Renee Lentini (VP)
Theresa Wingrove (SVP)
Kristine Peterson (Director)
Learn More about top insider investors at ImmunoGen.